Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
114.01
+1.58 (1.40%)
Aug 6, 2025, 3:31 PM EDT
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
$727,251
Profits / Employee
$179,935
Market Cap
221.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
Novartis AG News
- 5 days ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 6 days ago - Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use - PRNewsWire
- 6 days ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 6 days ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters
- 6 days ago - Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days - CNBC
- 8 days ago - Trump's pharmaceutical tariffs could affect some drugmakers more than others - CNBC
- 12 days ago - 3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs - Benzinga
- 13 days ago - Matchpoint in pact with Novartis for inflammatory disease treatments - Seeking Alpha